Your Location:
Home >
Browse articles >
Effect of Modified Erchentang on CC16, SP-D and HAT and HDAC in Patients at Acute Exacerbation Stage of COPD
Effect of Modified Erchentang on CC16, SP-D and HAT and HDAC in Patients at Acute Exacerbation Stage of COPD
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 10, Pages: 163-170(2017)
DOI: 10.13422/j.cnki.syfjx.2017100163
Scan QR Code
Full Text(HTML)
Publication Info
Metrics
22
Views
37
Downloads
15
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
Effect of Modified Erchentang on Hif-1 and Sirtuins 1 in Patients with COPD
Erchentang Alleivates Depression in Obese Mice by Regulating PPAR Signaling Pathway
Erchentang Ameliorates SiO2-induced Lung Injury by Regulating Oxidative Stress and Metabolic Disorders via Nrf2/HO-1 Signaling Pathway
Mechanism of Erchentang Improving Obesity in Mice by Inducing Browning of White Adipose Tissue Based on AMPK/PGC-1α Signaling Pathway
Related Author
Li-zhi SHANG
Shu JI
Yao-yang LI
Meng-di MAO
Guo-qiang WANG
Long-tao SHI
Guang-yuan ZHANG
Li-li XU
Related Institution
Henan University of Chinese Medicine
Hubei Shizhen Laboratory
School of Basic Medical Sciences, Hubei University of Chinese Medicine
Central Theater Command General Hospital of the People's Liberation Army
Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine


